CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 4 enrolled
Drug / intervention
Otterooother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03502265
NCT03502265N/ACompleted

Exploring Otteroo Use In Early Intervention: A Case Series

University of Southern California·interventional·Posted Apr 18, 2018·Updated Nov 23, 2021

In Brief

A clinical study evaluating Otteroo for Infants With or at Risk/Concern for Developmental Delay. Completed, enrolled 4 participants across 1 site.

Detailed Summary

Rationale. The Otteroo is a floatie which supports an infant or young child with their head above and their body in water. Researchers are proposing that the Otteroo may be a good "tool" to facilitate exploring the ability to move and control one's body before locomotion develops. Intervention. Otteroo will be used as an adjunct to standard care for 4 weeks.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedApr 18, 2018
Enrollment StartApr 3, 2018
Primary CompletionSep 1, 2019
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 8.2 years ago

Interventions

Otterooother

Otteroo will be provided for 4 weeks of use, to supplement any standard care. Standard care is not provided.